Filing Details
- Accession Number:
- 0001181431-13-053974
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-16 12:26:51
- Reporting Period:
- 2013-05-17
- Filing Date:
- 2013-10-16
- Accepted Time:
- 2013-10-16 12:26:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131543 | Ambit Biosciences Corp | AMBI | Pharmaceutical Preparations (2834) | 330909648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1562157 | Foresite Capital Fund I, L.p. | 3052 Pacific Avenue San Francisco CA 94115 | No | No | Yes | No | |
1581219 | Foresite Capital Management I, Llc | 3052 Pacific Avenue San Francisco CA 94115 | No | No | Yes | No | |
1581754 | B. James Tananbaum | 3052 Pacific Avenue San Francisco CA 94115 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-17 | 36,616 | $6.77 | 2,036,616 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-05-20 | 8,120 | $6.90 | 2,044,736 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-05-21 | 1,811 | $6.84 | 2,046,547 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-05-22 | 5,005 | $6.74 | 2,051,552 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-06-03 | 10,000 | $6.99 | 2,061,552 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-06-12 | 5,700 | $7.45 | 2,067,252 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-06-14 | 7,500 | $7.46 | 2,074,752 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2013-06-24 | 4,817 | $6.77 | 2,079,569 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Footnotes
- Shares are owned directly by Foresite Capital Fund I, L.P. ("FCF I"). Foresite Capital Management I, LLC ("FCM I"), the Designated Filer and general partner of FCF I, may be deemed to have the sole voting and dispositive power over 2,074,752 shares of the Issuer's Common Stock. James Tananbaum ("Tananbaum"), in his capacity as managing member of FCM I, may be deemed to have the sole voting and dispositive power over 2,074,752 shares of the Issuer's Common Stock.